In this study, we investigated Lzts1 role in taxanes-resistance in breast cancer, targeting endogenous LZTS1 by shRNA in MCF7, MDA-MC231, MDA-MB463, and T-47D breast cancer cells. This evidence concerns the gene LZTS1 and breast carcinoma.